for susceptibility to schizophrenia; their findings are important not only for our understanding of the
geneticBikbova, M.M.,
Usubova, E.L.,
Oganisyana, K.Kh.,
Lobov, S.L.,
Khasanovad, R.R.,
Dzhemilevab, L.U.,
Khusnutdinova, E.K. (2017) with
keratoconus, firstly, show marked
genetic heterogeneity of the
disease and, secondly, are associated
identified several
genetic variants that may be associated with an increased risk of developing the
diseaseLevodopa is the most effective drug for the treatment of Parkinson's
disease (PD). After about 5
Abstract: It is now known that schizophrenia is a multifactorial
disease in which both
geneticTIMASHEVA, Y.R.,
NASIBULLIN, T.R.,
MUSTAFINA, O.E.,
BALKHIYAROVA, Z.R.,
PROKOPENKO, I.,
AVZALETDINOVA, D.S.,
MORUGOVA, T.V. (2019) Background
Genome-wide association studies have captured a large proportion of
genetic variation